The molecular biology of chronic myeloid leukemia-Reference-Cited by-同舟云学术

The molecular biology of chronic myeloid leukemia

Published:2000-11-15 Issue:10 Volume:96 Page:3343-3356
ISSN:1528-0020
Container-title:Blood
language:en
Short-container-title:

Author:

Deininger Michael W. N.¹,Goldman John M.¹,Melo Junia V.¹

Affiliation:

1. From the Department of Hematology/Oncology, University of Leipzig, Germany; and the Department of Haematology, Imperial College School of Medicine, Hammersmith Hospital, London, United Kingdom.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/96/10/3343/1669327/h8220003343.pdf

Reference214 articles.

1. A minute chromosome in human chronic granulocytic leukemia.;Nowell;Science.,1960

2. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining [letter].;Rowley;Nature.,1973

3. Translocation of c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia.;Bartram;Nature.,1983

4. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22.;Groffen;Cell.,1984

5. Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.;Lugo;Science.,1990

Cited by 1254 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure‐Guided Drug Design Targeting Abl Kinase: How Structure and Regulation Can Assist in Designing New Drugs;ChemBioChem;2024-09-12

2. Establishment of genomic RNA reference materials for BCR-ABL1 P210 measurement;Analytical and Bioanalytical Chemistry;2024-09-09

3. A Novel Next-Generation Sequencing Assay for the Identification of BCR::ABL1 Transcript Type and Accurate and Sensitive Detection of TKI-Resistant Mutations;The Journal of Applied Laboratory Medicine;2024-09-03

4. Discovery of therapeutic targets in cancer using chromatin accessibility and transcriptomic data;Cell Systems;2024-09

5. Cytosolic delivery of monobodies using the bacterial type III secretion system inhibits oncogenic BCR::ABL1 signaling;2024-08-05